Study on Radiotherapy with Cisplatin vs. Docetaxel-Cetuximab for Head and Neck Cancer: Exploring ERCC1 Biomarker Effects | Clinical Trial

Study on Radiotherapy with Cisplatin vs. Docetaxel-Cetuximab for Head and Neck Cancer: Exploring ERCC1 Biomarker Effects | Clinical Trial | Right2Hope